An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics
用户zdYpIJ2_nLXQ
10天前
46
10
已完结
1. 系统已在2026-03-09 10:38:09对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1177/10915818261417235
文献链接: https://journals.sagepub.com/doi/10.1177/10915818261417235
其他信息:
出版社: SAGE Publications
作者: Jennifer D Sisler; Patrik Andersson; Alan Brown; Carole Harbison; Onyi Irrechukwu; Helen Lightfoot; Michaël Maes; Sucheta Mukherjee; Joel D Parry; Justin Schumacher; Anna Westlind Johnsson; Yi Yang; Tod A Harper
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1177/10915818261417235
